Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Prostate Cancer

Interventions

DIETARY_SUPPLEMENT

calcitriol

DRUG

mitoxantrone hydrochloride

DRUG

prednisone

Trial Locations (1)

Cancer Institute at Oregon Health and Science University, Portland

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT00182741 - Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter